Advertisement
Screener

Eagle Pharmaceuticals, Inc. Interest Expense on Debt

Eagle Pharmaceuticals, Inc. Interest Expense on Debt

Eagle Pharmaceuticals, Inc. reported Interest Expense on Debt of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseDebt · last filed 2016-02-29

  • Eagle Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2014-12-31 was $0.00.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2014-09-30 was $0.00.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for fiscal 2015 was $0.00.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for fiscal 2013 was $545.00K, a 400.00% increase from fiscal 2012.
  • Eagle Pharmaceuticals, Inc. interest expense, debt for fiscal 2012 was $109.00K.
Period endInterest Expense, Debt 3 monthInterest Expense, Debt 6 monthInterest Expense, Debt 9 monthInterest Expense, Debt 12 month
2015-12-31$0.00
10-K · filed 2016-02-29
2014-12-31$0.00
10-K · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$0.00
derived: sum of 3 quarters · filed 2016-02-29
$0.00
derived: sum of 4 quarters · filed 2016-02-29
2014-09-30$0.00
10-K · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$0.00
derived: sum of 3 quarters · filed 2016-02-29
$0.00
10-K · filed 2016-02-29
2014-06-30$0.00
10-Q · filed 2014-08-11
$0.00
derived: sum of 2 quarters · filed 2014-08-11
$0.00
10-Q · filed 2014-08-11
2014-03-31$0.00
10-Q · filed 2014-05-15
2013-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$218.00K
derived: sum of 2 quarters · filed 2016-02-29
$382.00K
derived: sum of 3 quarters · filed 2016-02-29
$545.00K
10-K · filed 2016-02-29
2013-06-30$218.00K
10-Q · filed 2014-08-11
$382.00K
derived: sum of 2 quarters · filed 2014-08-11
$545.00K
10-Q · filed 2014-08-11
2013-03-31$164.00K
10-Q · filed 2014-05-15
$328.00K
10-Q · filed 2014-05-15
2012-09-30$109.00K
10-K · filed 2014-12-22